G01N 2405/04
Phospholipids, i.e. phosphoglycerides
G01N2405/04 (Phospholipids, i.e. phosphoglycerides) appears on 227 US grants and 305 published applications in this corpus.
Search patents in G01N- Granted patents
- 227
- Published applications
- 305
- Assignees
- 224
- Inventors
- 686
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 6 | 0 |
| 1995 | 5 | 0 |
| 1996 | 5 | 0 |
| 1997 | 3 | 0 |
| 1998 | 9 | 0 |
| 1999 | 8 | 0 |
| 2000 | 4 | 0 |
| 2001 | 8 | 2 |
| 2002 | 3 | 5 |
| 2003 | 2 | 6 |
| 2004 | 2 | 7 |
| 2005 | 2 | 5 |
| 2006 | 4 | 2 |
| 2007 | 3 | 4 |
| 2008 | 1 | 2 |
| 2009 | 2 | 7 |
| 2010 | 2 | 6 |
| 2011 | 3 | 7 |
| 2012 | 5 | 8 |
| 2013 | 3 | 11 |
| 2014 | 2 | 7 |
| 2015 | 6 | 24 |
| 2016 | 9 | 20 |
| 2017 | 3 | 22 |
| 2018 | 12 | 31 |
| 2019 | 11 | 10 |
| 2020 | 16 | 28 |
| 2021 | 16 | 16 |
| 2022 | 17 | 19 |
| 2023 | 13 | 17 |
| 2024 | 3 | 17 |
| 2025 | 12 | 12 |
| 2026 | 6 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Metabolic biomarkers of inflammatory bowel disease6 Oct 2026US 12,754,192 B2Institut de Cardiologie de Montreal
- Methods for detection of pathogenic antiphospholipid antibodies and for identification of inhibitors29 Sep 2026US 12,748,111 B2The Scripps Research Institute
- Lipidomics-based identification of pancreatic cancer patients16 Jun 2026US 12,656,347 B2The Feinstein Institutes for Medical Research
- Rapid evaporative ionisation mass spectrometry (“REIMS”) and desorption electrospray ionisation mass spectrometry (“DESI-MS”) analysis of swabs and biopsy samples2 Jun 2026US 12,646,702 B2Micromass UK Limited
- Assay for measuring binding affinity for cardiolipin of biologically active compounds12 May 2026US 12,625,142 B2Latvian Institute of Organic Synthesis
- Methods of assessing metabolic health17 Sep 2026US 2026/0276661 A1Baker Heart and Diabetes Institute
- Compositions And Methods For Detecting Proteins In Protein Corona10 Sep 2026US 2026/0266834 A1Board of Trustees of Michigan State University
- Rapid evaporative ionisation mass spectrometry ("reims") and desorption electrospray ionisation mass spectrometry ("desi-ms") analysis of swabs and biopsy samples10 Sep 2026US 2026/0269206 A1Micromass UK Limited
- Method of providing early intervention to a newborn or infant with autism spectrum disorder16 Jul 2026US 2026/0202427 A1The Regents of the University of California
- Markers for the diagnosis of biochemical recurrence in prostate cancer2 Apr 2026US 2026/0092922 A1BPGbio, Inc.
Most cited
By later US patents
- Determination of biological characteristics of embryos fertilized in vitro by assaying for bioactive lipids in culture media142US 6,489,135 B1AtairginTechnologies, Inc. · 2002
- Liquid trap or separator for electrosurgical applications134US 10,916,415 B2Micromass UK Limited · 2021
- Biosensor arrays and methods77US 6,699,719 B2Proteomic Systems, Inc. · 2004
- Treatment of bleeding with modified tissue factor in combination with an activator of FVII62US 5,504,064 AOklahoma Medical Research Foundation · 1996
- Treatment of bleeding with modified tissue factor in combination with FVIIa60US 5,374,617 AOklahoma Medical Research Foundation · 1994